3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 23.00
-0.04 (-0.17%)
At close: Feb 3, 2026
3SBio Market Cap
3SBio has a market cap or net worth of 57.55 billion as of February 3, 2026. Its market cap has increased by 329.41% in one year.
Market Cap
57.55B
Enterprise Value
55.39B
Revenue
9.94B
Ranking
n/a
PE Ratio
21.93
Stock Price
23.00
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 57.55B, an increase of 153.86%. That is a compound annual growth rate of 9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 57.55B | -4.71% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 140.68B |
| Sino Biopharmaceutical | 118.70B |
| Akeso | 101.69B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.87B |
| RemeGen | 57.77B |
| Shanghai Junshi Biosciences | 36.42B |
| TransThera Sciences (Nanjing) | 32.98B |
| Biocytogen Pharmaceuticals (Beijing) | 32.27B |